李燕

个人信息Personal Information

副教授

硕士生导师

性别:女

毕业院校:大连理工大学

学位:博士

所在单位:化工学院

电子邮箱:yanli@dlut.edu.cn

扫描关注

论文成果

当前位置: 中文主页 >> 科学研究 >> 论文成果

Structure Requirements for 4-Aryl-4H-Chromenes as Apoptosis Inducers Using 3D QSAR Methods and Docking Studies

点击次数:

论文类型:期刊论文

发表时间:2012-06-01

发表刊物:ASIAN JOURNAL OF CHEMISTRY

收录刊物:SCIE、Scopus

卷号:24

期号:6

页面范围:2450-2460

ISSN号:0970-7077

关键字:Chromenes; Apoptosis inducer; CoMFA; CoMSIA; Caspase-3; Tubulin

摘要:Presently, a computational study based on the combinational use of 3D-quantitative structure-activity relationship analyses (QSAR) methods including both the comparative molecular field analysis (CoMFA) and comparative molecular similarity analysis (CoMSIA) approaches and molecule docking was conducted on a series of 124 types of 4-aryl-4H-chromenes of 24 diverse structural scaffolds as promising novel apoptosis inducers, with purpose to explore the requisite structural features influencing their activity of caspase-3 activation in human breast tumor cells. The obtained 3D-QSAR models exhibited proper reliability and predictivity, where the optimal comparative molecular field analysis and comparative molecular similarity analysis ones gave leave-one-out cross-validation coefficient Q(2) of 0.508 and 0.477, conventional cross-validation coefficient R-ncv(2), of 0.888 and 0.816 for the training set and predictive correlation coefficients R-prc(2) of 0.604 and 0.150 for the independent test set, respectively. Analyses of the derived contour maps reveal that steric substituents at positions 4, 9-13, 15 and 16 favour the apoptosis inducing activity and electron-withdrawing groups at 6 and 10 positions or electron-donating groups at position-7 enhance the activity. Further docking study validates that 4-aryl-4H-chromenes bind at the colchicine site of tubulin and several hydrogen bonds serve to stabilize the ligand-tubulin complex. These models and the derived information, would be of value for further exploration of the apoptosis inducing mechanism and the screening of novel potent chromene-based apoptosis inducers.